$28.85
-6.9%HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases worldwide. Its HeartFlow Platform uses AI and computational fluid dynamics to creates a personalized 3D model of a patient's heart from a single coronary computed tomography angiography, a specialized type of scan that provides detailed images of the heart's arteries. The company's platform provides insights on blood flow, stenosis, and plaque volume and composition by overcoming the limitations of traditional non-invasive imaging tests. The company was founded in 2007 and is headquartered in Mountain View, California.
No management information found for htfl.
During the last 12 months, insiders have purchased $1.05M and sold $121.27M worth of HTFL shares, resulting in $120.22M of net selling activity.
0
0.00
2.1M
62.51M
-62.5M
-$62.51M
40.0K
1.05M
2.1M
58.76M
-57.7M
-$57.71M
0
0.00
0
0.00
+0
+$0
0
0.00
0
0.00
+0
+$0
Lightcap Jeffrey C
Director
$1.05M
Bain Capital Life Sciences Investors, Llc
10 Percent Owner
$113.31M
Rogers Campbell
Officer: Chief Medical Officer
$5.10M
Farquhar John C.M.
Director, Officer: Chief Executive Officer
$2.41M
Cullivan Julie A
Director
$447K
Strong bearish signal with $120.22M net selling. Heavy insider selling may indicate concerns about valuation or near-term prospects.
Very poor ratio. Heavy selling with minimal buying suggests insiders may be concerned about valuation or outlook.
Heavy recent selling activity. Recent insider sales notably exceed purchases—may warrant investigation into company developments.
4 insider sellers vs. 1 buyers. Widespread selling across multiple insiders may signal concerns.
Multiple red flags: Heavy selling, numerous sellers, and continued recent selling create a concerning pattern. Investigate fundamental drivers and consider whether company guidance or industry conditions have deteriorated.
HTFL - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2026 N/A | April 29, 2026 | June 16, 2026 | 2026 |
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.